Concepedia

Debora Rubio-Aparicio

DR

Statistics

Publications

14

Citations

1.3K

H-Index

14

Active since

2017

Affiliations

Mapp Biopharmaceutical (United States)(Current)

Doctors Company (United States)

Molsoft (United States)

JMI Laboratories

Debora Rubio-Aparicio is an author at Mapp Biopharmaceutical (United States) specializing in antibiotic resistance, antimicrobial resistance, and life sciences.

Publications per year

2017–2023

14

Publications

14

Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae

Olga Lomovskaya, Dongxu Sun, Debora Rubio-Aparicio et al. · Antimicrobial Agents and Chemotherapy · 2017 · 347 citations · Full text

, , +17

Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases

Scott J. Hecker, K. Raja Reddy, Olga Lomovskaya et al. · Journal of Medicinal Chemistry · 2020 · 212 citations · Full text

, , +17

Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity

Kirk Nelson, Peera Hemarajata, Dongxu Sun et al. · Antimicrobial Agents and Chemotherapy · 2017 · 176 citations · Full text

, , +17

Meropenem-Vaborbactam Resistance Selection, Resistance Prevention, and Molecular Mechanisms in Mutants of KPC-Producing Klebsiella pneumoniae

Dongxu Sun, Debora Rubio-Aparicio, Kirk Nelson et al. · Antimicrobial Agents and Chemotherapy · 2017 · 166 citations · Full text

, , +17

Spectrum of Beta-Lactamase Inhibition by the Cyclic Boronate QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases: Enhancement of Activity of Multiple Antibiotics against Isogenic Strains Expressing Single Beta-Lactamases

Olga Lomovskaya, Ruslan Tsivkovski, Kirk Nelson et al. · Antimicrobial Agents and Chemotherapy · 2020 · 52 citations · Full text

, , +17

1–5 of 14